Literature DB >> 3966978

The response to cytotoxic drugs of EMT6 cells treated either as intact or disaggregated spheroids.

T T Kwok, P R Twentyman.   

Abstract

We have compared the response to a number of cytotoxic drugs of cells treated either within intact multicellular spheroids or as isolated cells following spheroid disaggregation. The cells used were of the EMT6/Ca/VJAC mouse tumour line and spheroids were treated or disaggregated at a mean diameter of 250 micron. The response of cell to nitrogen mustard (HN2) or CCNU was similar under the two exposure conditions and we conclude that factors related to spheroid structure (i.e. drug penetrability, intercellular contact effect and microenvironment within the spheroid) do not influence the initial response to these agents. Recovery of potentially lethal damage occurring over 24 h, however, greatly modifies the level of cell killing in intact spheroids. EMT6 cells were found to be extremely resistant to vincristine under all exposure conditions. For adriamycin (ADM), cells were always initially more sensitive when exposed to the drug in suspension rather than in intact spheroids. When ADM exposure was prolonged beyond 1 h, however, delaying spheroid disaggregation for 24 h led to increased cell kill and reduced differential between the two conditions of exposure. The data suggest that both drug penetration problems and other factors related to spheroid structure are involved in determining the response of cells in small spheroids to ADM.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3966978      PMCID: PMC1977032          DOI: 10.1038/bjc.1985.31

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  15 in total

1.  Distribution of daunomycin and adriamycin in mice. A comparative study.

Authors:  R Rosso; M Esposito; R Sala; L Santi
Journal:  Biomedicine       Date:  1973-07-20

2.  Effects of intercellular contact on repair of radiation damage.

Authors:  R E Durand; R M Sutherland
Journal:  Exp Cell Res       Date:  1972-03       Impact factor: 3.905

3.  Resistance to adriamycin in multicellular spheroids.

Authors:  R M Sutherland; H A Eddy; B Bareham; K Reich; D Vanantwerp
Journal:  Int J Radiat Oncol Biol Phys       Date:  1979-08       Impact factor: 7.038

4.  A comparison of the pharmacokinetics of multiple and single dose administrations of adriamycin.

Authors:  D W Siemann; R M Sutherland
Journal:  Int J Radiat Oncol Biol Phys       Date:  1979-08       Impact factor: 7.038

5.  Effects of hyperthermia on the cycling, noncycling, and hypoxic cells of irradiated and unirradiated multicell spheroids.

Authors:  R E Durand
Journal:  Radiat Res       Date:  1978-08       Impact factor: 2.841

6.  Development of a 9L rat brain tumor cell multicellular spheroid system and its response to 1,3-bis(2-chloroethyl)-1-nitrosourea and radiation.

Authors:  D F Deen; T Hoshino; M E Williams; I Muraoka; K D Knebel; M Barker
Journal:  J Natl Cancer Inst       Date:  1980-06       Impact factor: 13.506

7.  Increased radioresistance of cells in cultured multicell spheroids. I. Dependence on cellular interaction.

Authors:  H Dertinger; D Hülser
Journal:  Radiat Environ Biophys       Date:  1981       Impact factor: 1.925

8.  Radiation response of multicell spheroids--an in vitro tumour model.

Authors:  R M Sutherland; R E Durand
Journal:  Curr Top Radiat Res Q       Date:  1976-01

9.  Response to chemotherapy of EMT6 spheroids as measured by growth delay and cell survival.

Authors:  P R Twentyman
Journal:  Br J Cancer       Date:  1980-08       Impact factor: 7.640

10.  Changes in sensitivity to cytotoxic agents occurring during the life history of monolayer cultures of a mouse tumour cell line.

Authors:  P R Twentyman; N M Bleehen
Journal:  Br J Cancer       Date:  1975-04       Impact factor: 7.640

View more
  8 in total

Review 1.  Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy.

Authors:  Geeta Mehta; Amy Y Hsiao; Marylou Ingram; Gary D Luker; Shuichi Takayama
Journal:  J Control Release       Date:  2012-05-18       Impact factor: 9.776

2.  Relations between the penetration, binding and average concentration of cytostatic drugs in human tumour spheroids.

Authors:  M Erlanson; E Daniel-Szolgay; J Carlsson
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

3.  Postconfluency MDCK monolayers as an in vitro model of solid tumor chemosensitivity.

Authors:  P Skehan; J Thomas; S J Friedman
Journal:  Cell Biol Toxicol       Date:  1986-09       Impact factor: 6.691

4.  Slow penetration of anthracyclines into spheroids and tumors: a therapeutic advantage?

Authors:  R E Durand
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

5.  Boron neutron capture therapy demonstrated in mice bearing EMT6 tumors following selective delivery of boron by rationally designed liposomes.

Authors:  Peter J Kueffer; Charles A Maitz; Aslam A Khan; Seth A Schuster; Natalia I Shlyakhtina; Satish S Jalisatgi; John D Brockman; David W Nigg; M Frederick Hawthorne
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-27       Impact factor: 11.205

Review 6.  Multicellular spheroids. A review on cellular aggregates in cancer research.

Authors:  W Mueller-Klieser
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

7.  The effect of adriamycin and 4'-deoxydoxorubicin on cell survival of human lung tumour cells grown in monolayer and as spheroids.

Authors:  D J Kerr; T E Wheldon; A M Kerr; R I Freshney; S B Kaye
Journal:  Br J Cancer       Date:  1986-09       Impact factor: 7.640

8.  A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity.

Authors:  P R Twentyman; M Luscombe
Journal:  Br J Cancer       Date:  1987-09       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.